drugset / Trial / NCT02516150

Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon

NCT02516150

Phase 4 Completed 26 enrolled Massachusetts General Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

This study will test the hypothesis that a BAC (blood alcohol content) of 0.1% will not significantly alter the anti-hypoglycemic effect of mico-dose glucagon in individuals with type 1 diabetes.

Timeline

Start
2016-03
Primary completion
2017-05
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified Intravenous
Subject Glucagon Peptide 50 ug Subcutaneous